We are live on ! Find out more
INSM icon

Insmed
INSM

288 hedge funds and large institutions have $4.07B invested in Insmed in 2024 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 97 increasing their positions, 97 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 29

6% more funds holding

Funds holding: 271 → 288 (+17)

0% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 97

4.76% less ownership

Funds ownership: 105.75% → 100.99% (-4.8%)

13% less capital invested

Capital invested by funds: $4.69B → $4.07B (-$621M)

25% less funds holding in top 10

Funds holding in top 10: 8 → 6 (-2)

33% less call options, than puts

Call options by funds: $67.7M | Put options by funds: $101M

Holders
288
Holders Change
+17
Holders Change %
+6.27%
% of All Funds
4.15%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.09%
New
47
Increased
97
Reduced
97
Closed
29
Calls
$67.7M
Puts
$101M
Net Calls
-$33.1M
Net Calls Change
+$10.2M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$118M
2
Capital International Investors
Capital International Investors
California
+$45.4M
3
First Trust Advisors
First Trust Advisors
Illinois
+$37.5M
4
IHAM
Integral Health Asset Management
New York
+$26.6M
5
ClearBridge Investments
ClearBridge Investments
New York
+$26M

Top Sellers

1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$67.1M
2
Morgan Stanley
Morgan Stanley
New York
-$59.6M
3
Holocene Advisors
Holocene Advisors
New York
-$50M
4
Millennium Management
Millennium Management
New York
-$37.2M
5
PAI
Palo Alto Investors
California
-$30.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$394M +$10.7M +383,714 +3%
BlackRock
2
BlackRock
New York
$320M +$8.6M +307,419 +3%
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$292M +$157K +5,595 +0.1%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$253M +$118M +4,227,280 +83%
State Street
5
State Street
Massachusetts
$160M -$694K -24,806 -0.4%
DTC
6
Deep Track Capital
Connecticut
$130M -$15.8M -566,321 -11%
PAI
7
Palo Alto Investors
California
$120M -$30.5M -1,088,352 -20%
William Blair Investment Management
8
William Blair Investment Management
Illinois
$114M -$1.17M -41,968 -1%
Macquarie Group
9
Macquarie Group
Australia
$106M -$21M -751,988 -16%
Franklin Resources
10
Franklin Resources
California
$96.8M +$4.77M +170,286 +5%
T. Rowe Price Investment Management
11
T. Rowe Price Investment Management
Maryland
$93.6M -$67.1M -2,399,026 -41%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$85.8M +$2.64M +94,373 +3%
Ameriprise
13
Ameriprise
Minnesota
$74.2M +$12.7M +452,847 +20%
Janus Henderson Group
14
Janus Henderson Group
United Kingdom
$60.5M +$23.1M +826,372 +59%
AllianceBernstein
15
AllianceBernstein
Tennessee
$58.2M -$39.8K -1,423 -0.1%
BG
16
Bellevue Group
Switzerland
$58.1M -$4.17M -149,115 -7%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$55.7M -$8.55M -305,551 -13%
SCM
18
Suvretta Capital Management
New York
$54.9M -$18.5M -661,487 -25%
RI
19
RTW Investments
New York
$50.6M – – –
Capital International Investors
20
Capital International Investors
California
$44M +$45.4M +1,620,814 New
Norges Bank
21
Norges Bank
Norway
$43.1M +$3.79M +135,516 +9%
Pictet Asset Management
22
Pictet Asset Management
Switzerland
$41.5M -$12.1M -431,793 -22%
Loomis, Sayles & Company
23
Loomis, Sayles & Company
Massachusetts
$40.5M -$23.5M -839,711 -36%
Principal Financial Group
24
Principal Financial Group
Iowa
$39M +$2.23M +79,717 +6%
First Trust Advisors
25
First Trust Advisors
Illinois
$39M +$37.5M +1,341,242 +1,398%
1
2 3 4 5

INSM Hedge Fund Activity: Q1 2024 in Review

288 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q1 2024, worth a combined $4.07B — down 13% from $4.69B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new INSM positions and 29 closed out — a net gain of 18 holders — while 97 added to existing stakes and 97 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $118M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $67.1M.

  • 288 institutional investors held Insmed (INSM) as of Q1 2024, up from 271 in Q4 2023.
  • Funds reported $4.07B of Insmed stock for Q1 2024, down 13% quarter-over-quarter.
  • 47 funds opened new Insmed positions in Q1 2024 and 29 closed out, a net change of +18 holders.
  • The largest Insmed buyer in Q1 2024 was Fidelity Investments, an estimated $118M added.
  • The largest Insmed seller in Q1 2024 was T. Rowe Price Investment Management, an estimated $67.1M sold.

Based on aggregated 13F filings for Q1 2024.